Hydroxyurea

Form: Capsules and Tablets

Strength: Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg

Reference Brands: Hydrea, Droxia , Siklos

Category: Anemia

Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.